Three-Dimensional Blood-Brain Barrier Model for in vitro Studies of Neurovascular Pathology

Abstract

Blood–brain barrier (BBB) pathology leads to neurovascular disorders and is an important target for therapies. However, the study of BBB pathology is difficult in the absence of models that are simple and relevant. In vivo animal models are highly relevant, however they are hampered by complex, multi-cellular interactions that are difficult to decouple. In vitro models of BBB are simpler, however they have limited functionality and relevance to disease processes. To address these limitations, we developed a 3-dimensional (3D) model of BBB on a microfluidic platform. We verified the tightness of the BBB by showing its ability to reduce the leakage of dyes and to block the transmigration of immune cells towards chemoattractants. Moreover, we verified the localization at endothelial cell boundaries of ZO-1 and VE-Cadherin, two components of tight and adherens junctions. To validate the functionality of the BBB model, we probed its disruption by neuro-inflammation mediators and ischemic conditions and measured the protective function of antioxidant and ROCK-inhibitor treatments. Overall, our 3D BBB model provides a robust platform, adequate for detailed functional studies of BBB and for the screening of BBB-targeting drugs in neurological diseases.

[O2–04–01]: Clearance of Beta‐amyloid Is Facilitated by Apolipoprotein E and Circulating High‐density Lipoproteins in Bioengineered Human Vessels

“…Considerable recent advances in tissue engineering technology have helped to develop microfluidic systems (i.e. 'organ on a chip') that recapitulate the 3D complexity of the BBB, primarily to produce small vessel structures like capillaries (Prabhakarpandian et al, 2013;Herland et al, 2016;Booth and Kim, 2012;Griep et al, 2013;Cho et al, 2015). However, as CAA preferentially forms in larger arteries, we aimed to produce 3D in vitro models of functional human vessels that retain the anatomical and functional properties of native human cerebral arteries.…”

New experimental models of the blood-brain barrier for CNS drug discovery

“…Microvascular modeling in the form of microfluidic devices in recent years has addressed these concerns by enabling the formation of pro-angiogenic interstitial gradients of growth factors (VEGF, b-FGF and PMA supplemented media) [72] as well as continuous endothelial exposure to shear stress [72, 73, 74]. In most of these in vitro models, collagen type I has been used as the ECM of choice [72, 74, 75]. Collagen is a naturally derived hydrogel isolated from various biological sources including bovine skin and rat tail tendon [76].…”

In vitro screening of nanomedicines through the blood brain barrier: A critical review

“…To downsize the cell-based BBB models and hence reduce the amount of cells required for the assay, microfluidic models have been recently put forward [295,296]. These models represent a coculture of cells of the neurovascular unit seeded on a porous membrane in contact mode.…”